Hospitalized infections in giant cell arteritis - A population-based retrospective cohort study

Prabhu D. Udayakumar, Arun K. Chandran, Cynthia Crowson, Kenneth J Warrington, Eric Lawrence Matteson

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective. To assess the occurrence of infections requiring or acquired during hospitalization in patients with giant cell arteritis (GCA). Methods. We retrospectively reviewed a population-based incidence cohort of patients with GCA diagnosed between 1950 and 2009 and compared this cohort with a non-GCA one matched for age, sex, and calendar year from the same population. Results. We identified 245 patients in the GCA cohort and 245 patients in the non-GCA cohort. Seventy-four GCA subjects (134 episodes) and 79 non-GCA (153 episodes) had infections requiring or acquired during hospitalization [rate ratio (RR) 0.94; 95% CI 0.74, 1.18]. Sixty-seven subjects (107 episodes) in the GCA cohort and 63 subjects (110 episodes) in non-GCA cohort required hospitalization secondary to an infection (RR 1.04; CI 0.80, 1.36). Pneumonia, urinary tract infections (UTI), skin and soft tissue infections accounted for the majority of infections requiring hospitalization and had similar occurrence in both cohorts. UTI accounted for the majority of infections requiring hospitalization in the first 6 months after GCA incidence (RR 3.93; CI 0.85, 56.52). No difference between the 2 cohorts was noted in overall infections acquired during hospitalization (RR 0.68; CI 0.41, 1.08). Conclusion. There is no overall increased risk of infections requiring or acquired during hospitalization in patients with GCA who are taking glucocorticoid therapy. There may be an increased risk of infections requiring hospitalization, especially of the urinary tract, in the first 6 months after GCA incidence, although this did not achieve statistical significance in our study.

Original languageEnglish (US)
Pages (from-to)2447-2451
Number of pages5
JournalJournal of Rheumatology
Volume41
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Giant Cell Arteritis
Hospitalization
Cohort Studies
Retrospective Studies
Arteritis
Infection
Population
Urinary Tract Infections
Incidence
Soft Tissue Infections
Urinary Tract
Coinfection
Glucocorticoids
Pneumonia
Skin

Keywords

  • Cohort studies
  • Giant cell arteritis
  • Hospitalization
  • Infection

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Hospitalized infections in giant cell arteritis - A population-based retrospective cohort study. / Udayakumar, Prabhu D.; Chandran, Arun K.; Crowson, Cynthia; Warrington, Kenneth J; Matteson, Eric Lawrence.

In: Journal of Rheumatology, Vol. 41, No. 12, 01.12.2014, p. 2447-2451.

Research output: Contribution to journalArticle

@article{ba9785e6ca5c48c7bc1ab3db57dc95b7,
title = "Hospitalized infections in giant cell arteritis - A population-based retrospective cohort study",
abstract = "Objective. To assess the occurrence of infections requiring or acquired during hospitalization in patients with giant cell arteritis (GCA). Methods. We retrospectively reviewed a population-based incidence cohort of patients with GCA diagnosed between 1950 and 2009 and compared this cohort with a non-GCA one matched for age, sex, and calendar year from the same population. Results. We identified 245 patients in the GCA cohort and 245 patients in the non-GCA cohort. Seventy-four GCA subjects (134 episodes) and 79 non-GCA (153 episodes) had infections requiring or acquired during hospitalization [rate ratio (RR) 0.94; 95{\%} CI 0.74, 1.18]. Sixty-seven subjects (107 episodes) in the GCA cohort and 63 subjects (110 episodes) in non-GCA cohort required hospitalization secondary to an infection (RR 1.04; CI 0.80, 1.36). Pneumonia, urinary tract infections (UTI), skin and soft tissue infections accounted for the majority of infections requiring hospitalization and had similar occurrence in both cohorts. UTI accounted for the majority of infections requiring hospitalization in the first 6 months after GCA incidence (RR 3.93; CI 0.85, 56.52). No difference between the 2 cohorts was noted in overall infections acquired during hospitalization (RR 0.68; CI 0.41, 1.08). Conclusion. There is no overall increased risk of infections requiring or acquired during hospitalization in patients with GCA who are taking glucocorticoid therapy. There may be an increased risk of infections requiring hospitalization, especially of the urinary tract, in the first 6 months after GCA incidence, although this did not achieve statistical significance in our study.",
keywords = "Cohort studies, Giant cell arteritis, Hospitalization, Infection",
author = "Udayakumar, {Prabhu D.} and Chandran, {Arun K.} and Cynthia Crowson and Warrington, {Kenneth J} and Matteson, {Eric Lawrence}",
year = "2014",
month = "12",
day = "1",
doi = "10.3899/jrheum.140124",
language = "English (US)",
volume = "41",
pages = "2447--2451",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "12",

}

TY - JOUR

T1 - Hospitalized infections in giant cell arteritis - A population-based retrospective cohort study

AU - Udayakumar, Prabhu D.

AU - Chandran, Arun K.

AU - Crowson, Cynthia

AU - Warrington, Kenneth J

AU - Matteson, Eric Lawrence

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Objective. To assess the occurrence of infections requiring or acquired during hospitalization in patients with giant cell arteritis (GCA). Methods. We retrospectively reviewed a population-based incidence cohort of patients with GCA diagnosed between 1950 and 2009 and compared this cohort with a non-GCA one matched for age, sex, and calendar year from the same population. Results. We identified 245 patients in the GCA cohort and 245 patients in the non-GCA cohort. Seventy-four GCA subjects (134 episodes) and 79 non-GCA (153 episodes) had infections requiring or acquired during hospitalization [rate ratio (RR) 0.94; 95% CI 0.74, 1.18]. Sixty-seven subjects (107 episodes) in the GCA cohort and 63 subjects (110 episodes) in non-GCA cohort required hospitalization secondary to an infection (RR 1.04; CI 0.80, 1.36). Pneumonia, urinary tract infections (UTI), skin and soft tissue infections accounted for the majority of infections requiring hospitalization and had similar occurrence in both cohorts. UTI accounted for the majority of infections requiring hospitalization in the first 6 months after GCA incidence (RR 3.93; CI 0.85, 56.52). No difference between the 2 cohorts was noted in overall infections acquired during hospitalization (RR 0.68; CI 0.41, 1.08). Conclusion. There is no overall increased risk of infections requiring or acquired during hospitalization in patients with GCA who are taking glucocorticoid therapy. There may be an increased risk of infections requiring hospitalization, especially of the urinary tract, in the first 6 months after GCA incidence, although this did not achieve statistical significance in our study.

AB - Objective. To assess the occurrence of infections requiring or acquired during hospitalization in patients with giant cell arteritis (GCA). Methods. We retrospectively reviewed a population-based incidence cohort of patients with GCA diagnosed between 1950 and 2009 and compared this cohort with a non-GCA one matched for age, sex, and calendar year from the same population. Results. We identified 245 patients in the GCA cohort and 245 patients in the non-GCA cohort. Seventy-four GCA subjects (134 episodes) and 79 non-GCA (153 episodes) had infections requiring or acquired during hospitalization [rate ratio (RR) 0.94; 95% CI 0.74, 1.18]. Sixty-seven subjects (107 episodes) in the GCA cohort and 63 subjects (110 episodes) in non-GCA cohort required hospitalization secondary to an infection (RR 1.04; CI 0.80, 1.36). Pneumonia, urinary tract infections (UTI), skin and soft tissue infections accounted for the majority of infections requiring hospitalization and had similar occurrence in both cohorts. UTI accounted for the majority of infections requiring hospitalization in the first 6 months after GCA incidence (RR 3.93; CI 0.85, 56.52). No difference between the 2 cohorts was noted in overall infections acquired during hospitalization (RR 0.68; CI 0.41, 1.08). Conclusion. There is no overall increased risk of infections requiring or acquired during hospitalization in patients with GCA who are taking glucocorticoid therapy. There may be an increased risk of infections requiring hospitalization, especially of the urinary tract, in the first 6 months after GCA incidence, although this did not achieve statistical significance in our study.

KW - Cohort studies

KW - Giant cell arteritis

KW - Hospitalization

KW - Infection

UR - http://www.scopus.com/inward/record.url?scp=84915774199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915774199&partnerID=8YFLogxK

U2 - 10.3899/jrheum.140124

DO - 10.3899/jrheum.140124

M3 - Article

C2 - 25320223

AN - SCOPUS:84915774199

VL - 41

SP - 2447

EP - 2451

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 12

ER -